Download Medical Notes on Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations

Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations Medical Notes

About This Presentation

Description:This report titled, “Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations” is by the IQVIA Institute and is an analysis of the orphan drug market. The report explores this topic of orphan drugs’ orphan and non-orphan indication approvals and their associated patent and market exclusivities. The report also examines orphan drug pricing relative to patient numbers, how those prices change over time, and – in a first-of-its-kind comprehensive analysis – compares current disease epidemiology to the number of treated patients to demonstrate the challenges in bringing orphan drugs to patients even after they are approved.

Tags:Healthcare, Orphan Drugs, United States, market, pricing, disease epidemiology

Published on: Jul 20, 2020 | Views : 1557 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

MEDICAL MARKETING IN PROMOTING MEDICAL TOURISM IN INDIA

About : I am a passionate medical marketing professional with hands on experience in healthcare digital marketing.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : India
Website :

MEDICAL MARKETING IN PROMOTING MEDICAL TOURISM IN INDIA

The Beginning of Human Life and Prevention of Chronic Disease: Reframing the First 1,000 Days

Emerging Biopharma’s Contribution to Innovation

Understanding the Global Landscape of Genomic Initiatives

Fight to Reduce Cancer Mortality

Electrolyte Disorders

Pharma 2020 Marketing the future - a paper on the future of the pharmaceutical industry

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

EvaluatePharma pharmaceutical industry world review 2019 and outlook 2024

Pharma 2020 Taxing times ahead

HEALTH A TO Z